Welcome back to another edition of Endpoints Weekly! We’ll get to the headlines in just a bit, but be sure to check out the ...
Legend Biotech has tapped Novartis executive Ingrid Zhang as its new CEO at a time when the company is seeking its next act.
Endpoints takes its China biotech debate to DC: four Post-Hoc Live conversations on patents, FDA data, biosecurity and ...
China's new five-year plan targets 20% annual pharma revenue growth and a quarter of the world's first-in-class drugs by 2030 ...
The FDA approved a new combination regimen from Eli Lilly for certain breast cancer patients, a regimen that includes Lilly’s oral selective estrogen receptor degrader (SERD) ...
CMS signaled drugmakers joining its Generous Medicaid rebate demo would be exempt from the Globe and Guard Medicare pilots, ...
Six UK parliamentary committees ask the National Audit Office to probe the cost of the £1B UK-US pharma deal and its NHS ...
CART01; Ori bags $120M deal; Reckitt invests $600M in US; Astellas expands Ireland; Hovione opens NJ facility.
FDA grants accelerated approval to Ultragenyx's Sanfilippo gene therapy UX111, weeks after the biotech's Angelman Phase 3 ...
Michael J. Fox Foundation backs Ariadne Bio's AB-300 & launches $2.5B campaign. SK Bio pays $1.8M for 1ST-104. NICE backs ...
All 50 states, DC and Puerto Rico join CMS' Generous model, tying Medicaid drug prices to what other wealthy countries pay.
Anthropic launched a Life Sciences Verification Program, granting select researchers access to AI models Mythos, Opus, and Sonnet, while maintaining biosafety restrictions on high-risk biological ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results